[HTML][HTML] Synergistic targeting of TrxR1 and ATM/AKT pathway in human colon cancer cells
X Shen, Y Xia, H Lu, P Zheng, J Wang, Y Chen… - Biomedicine & …, 2024 - Elsevier
Abstract Thioredoxin reductase 1 (TrxR1) has emerged as a promising target for cancer
therapy. In our previous research, we discovered several new TrxR1 inhibitors and found …
therapy. In our previous research, we discovered several new TrxR1 inhibitors and found …
Synergistic targeting of TrxR1 and ATM/AKT pathway in human colon cancer cells.
X Shen, Y Xia, H Lu, P Zheng, J Wang… - Biomedicine & …, 2024 - europepmc.org
Thioredoxin reductase 1 (TrxR1) has emerged as a promising target for cancer therapy. In
our previous research, we discovered several new TrxR1 inhibitors and found that they all …
our previous research, we discovered several new TrxR1 inhibitors and found that they all …
Synergistic targeting of TrxR1 and ATM/AKT pathway in human colon cancer cells
X Shen, Y Xia, H Lu, P Zheng, J Wang… - Biomedicine & … - pubmed.ncbi.nlm.nih.gov
Thioredoxin reductase 1 (TrxR1) has emerged as a promising target for cancer therapy. In
our previous research, we discovered several new TrxR1 inhibitors and found that they all …
our previous research, we discovered several new TrxR1 inhibitors and found that they all …